A. Vanhove

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

W. Boersma, E. Nossent, J. Geelhoed, 2021, The Lancet Respiratory Medicine.

Long-term clinical outcomes of COVID-19 patients treated with imatinib

J. Twisk, A. Noordegraaf, H. Bogaard, 2022, The Lancet Respiratory Medicine.

Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

F. D. de Man, H. Bogaard, E. Duijvelaar, 2022, Journal of cardiovascular pharmacology.

Improvements on the design of carbon dioxide conversion to methanol process using Aspen Plus ® interface

Arthur L E M Vanhove, A. Vanhove, 2015 .